WC
DVAX

Wexford Capital’s Dynavax Technologies DVAX Stock Holding History

Wexford Capital’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-383,454
Closed -$4.56M – 231
2013
Q3 		$4.56M Sell
383,454
-21,987
-5% -$277K 0.38% 43
2013
Q2 		$4.46M Buy
+405,441
New +$8.54M 0.39% 43

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Wexford Capital's DVAX Position: Q4 2013 in Review

Wexford Capital sold out of Dynavax Technologies (DVAX) in Q4 2013, closing a stake of 383,454 shares — an estimated $4.56M sold.

Wexford Capital first reported a position in DVAX in Q2 2013 and held it in 2 quarters. The position peaked at $4.56M in Q3 2013. 117 funds tracked by Wall St. Rank hold DVAX as of Q4 2013.

  • Wexford Capital reported no remaining Dynavax Technologies position as of Q4 2013 after selling out during the quarter.
  • Wexford Capital sold 383,454 Dynavax Technologies shares in Q4 2013, an estimated $4.56M.
  • Wexford Capital first reported a position in Dynavax Technologies in Q2 2013 and held it in 2 quarters.
  • Wexford Capital's Dynavax Technologies position peaked at $4.56M in Q3 2013.
  • 117 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2013.

Based on Wexford Capital's 13F filing for Q4 2013, filed 14 Feb 2014.